Aerogen, the world leader in aerosol drug delivery continues to expand its international activities with the opening of its German Commercial Headquarters – Aerogen GmbH near Dusseldorf. The office will be located in Ernst-Dietrich-Platz 1, 40882 Ratingen
Headed up by Alyas Mussa, Clinical Sales Manager Germany, the team has grown to include seven Critical Care Specialists that will be located across Germany, as well as a local team in Ratingen.
Aerogen is seeing growing demand in Germany and other European countries. John Power, Aerogen CEO and Founder, states: “Germany is an extremely important market for Aerogen, and we look forward to strengthening our commitment here with a location near Dusseldorf. With an on-site office, we can now work more closely with our customers and partners to meet their individual needs and grow together.”
The announcement was made in the presence of Minister of State for Trade, Employment, Business, EU Digital Single Market and Data Protection, Pat Breen T.D. who is in Germany attending the Medica trade show to highlight the Irish Advantage of Irish medical technology companies to German buyers.
Speaking at the opening of Aerogen’s new office, Minister Pat Breen T.D. said: “Ireland is now globally recognised as a major centre of excellence in the medical technologies sector and Aerogen is a prime example of a hugely successful Irish medical technologies company, whose success has been built on innovation and having global ambition right from the start. The company is now synonymous with the effective treatment of respiratory illness among patient groups of all ages, and plays a critical role in emergency departments and intensive care units in over 75 countries worldwide. The opening of Aerogen’s new German office is yet another milestone in the company’s successful export strategy, which is not only creating jobs in Ireland, but in Germany and around the world.”
Welcoming today’s announcement, Julie Sinnamon, Enterprise Ireland CEO said “Aerogen has made an impressive impact internationally with offices in the UK, US, China, Dubai and now Germany, distributing its market leading products worldwide. The opening of Aerogen’s office in Germany, underpins Aerogen’s strengthening position in the German market. They are a stellar example of an Enterprise Ireland client achieving its global ambition.”
Aerogen is the world’s leading medical device company specialising in the design, manufacture and commercialisation of aerosol drug delivery systems. Aerogen’s patented vibrating mesh technology turns liquid medication into a fine particle mist, gently and effectively delivering drugs to the lungs of critically ill patients of all ages.
Employing over 150 experienced staff, Aerogen has a strong international presence with offices in Ireland, the UK, France, Germany, China, the United States, and The Middle East. By the end of 2017 over six million patients will have benefited from Aerogen technology.
Pictured L to R
Alyas Mussa, Aerogen, National Sales Manager Germany
Dr Tom Kelly, Director Industrial, Lifesciences and Consumer Products Division, Enterprise Ireland
Dr John Power, Founder and CEO Aerogen
Minister Pat Breen T.D
H.E Micheal Collins, Ambassador of Ireland to Germany
Eddie Goodwin, Manager Germany, Switzerland, Austria, Enterprise Ireland